Raymond James Financial
HALO icon

Raymond James Financial’s Halozyme HALO Stock Holding History

Raymond James Financial’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.7M Buy
290,531
+7,597
+3% +$536K 0.01% 1521
2025
Q4 		$19.1M Buy
282,934
+1,487
+0.5% +$100K 0.01% 1479
2025
Q3 		$20.6M Buy
281,447
+29,046
+12% +$1.93M 0.01% 1391
2025
Q2 		$13.1M Sell
252,401
-54,378
-18% -$3.09M ﹤0.01% 1672
2025
Q1 		$19.6M Sell
306,779
-149,995
-33% -$8.71M 0.01% 1326
2024
Q4 		$21.8M Buy
+456,774
New +$23.4M 0.01% 1237

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's HALO Position: Q1 2026 in Review

Raymond James Financial increased its Halozyme (HALO) stake by 2.7% in Q1 2026, buying an estimated $536K and bringing the position to 290,531 shares worth $18.7M. The position accounts for 0.01% of the portfolio, ranked #1521.

Raymond James Financial first reported a position in HALO in Q4 2024 and has held it in 6 quarters since. The position peaked at $21.8M in Q4 2024. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Raymond James Financial held 290,531 shares of Halozyme worth $18.7M as of Q1 2026.
  • Raymond James Financial bought 7,597 Halozyme shares in Q1 2026, an estimated $536K.
  • Halozyme made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1521 holding.
  • Raymond James Financial first reported a position in Halozyme in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Halozyme position peaked at $21.8M in Q4 2024.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.